Details for New Drug Application (NDA): 019669
✉ Email this page to a colleague
NDA 019669 describes QUESTRAN LIGHT, which is a drug marketed by Bristol Myers and is included in one NDA. Additional details are available on the QUESTRAN LIGHT profile page.
The generic ingredient in QUESTRAN LIGHT is cholestyramine. There are eight drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.
The generic ingredient in QUESTRAN LIGHT is cholestyramine. There are eight drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.
Summary for 019669
| Tradename: | QUESTRAN LIGHT |
| Applicant: | Bristol Myers |
| Ingredient: | cholestyramine |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;ORAL | Strength | EQ 4GM RESIN/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 5, 1988 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;ORAL | Strength | EQ 4GM RESIN/SCOOPFUL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 5, 1988 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
